Study of inherited genetic risk in lung and related cancers
Part of Cancer, Genetic & congenital, Lungs & breathing clinical trials.
This study looks for inherited (family-passed) genetic changes that may raise the risk of lung cancer and related thoracic cancers. It may help people and families understand their genetic risk by collecting health information and sometimes specimens from patients and relatives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or a close family member) have lung cancer or a strong family history of it
- You may qualify if genetic testing in blood or saliva found an inherited EGFR gene change (like T790M) or a related lung-cancer risk gene change
- You may qualify even if testing shows a “variant of uncertain significance,” if the lead investigator decides it fits
- You can include family members who may carry the same genetic change, or relatives who can help confirm family history
- You (or your parent/legal guardian/healthcare proxy) are able and willing to sign consent; otherwise you can’t join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at surveillance (watching closely), prevention, and early “interception” steps to lower the chance that cancer will develop or be found later. It is for people with genetic risk, past cancer treatment exposures, strong family history, or certain early pre-cancer or high-risk conditions.
This study looks at genetic (DNA) and molecular (cell-level) information related to lung cancer to better understand the disease. You may be invited if you have a confirmed primary lung cancer diagnosis, or if you are healthy with no cancer.
This study uses a blood test to look for signs of lung cancer in people who have never smoked or smoked very little. It focuses on Asian and Latinx communities because certain gene changes are more common in these groups.
This study looks at your family history and genetic factors to understand how non-small cell lung cancer (a common lung cancer type) behaves over time, especially when diagnosed young. It may help researchers predict outcomes and identify who could benefit from different care in the future.
This trial offers a low-dose chest CT scan to screen for lung cancer in family members of people with a specific genetic mutation driving their lung cancer. It aims to catch cancer early in those at higher risk.
This study looks at how a specific DNA genetic change (variant) runs within cancer families. It may help researchers better understand cancer risk and improve genetic testing and interpretation.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.